| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1541-7786.MCR-06-0297 |
| P698 | PubMed publication ID | 17699110 |
| P50 | author | Michael Baumann | Q59959645 |
| P2093 | author name string | H Peter Rodemann | |
| Mahmoud Toulany | |||
| P2860 | cites work | Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. | Q42827942 |
| P433 | issue | 8 | |
| P304 | page(s) | 863-872 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. | |
| P478 | volume | 5 |
| Q44636555 | Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells |
| Q26771165 | Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization |
| Q89967133 | Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance |
| Q38995143 | Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease |
| Q36128358 | Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer |
| Q37536691 | Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer. |
| Q38607113 | ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition |
| Q37286023 | Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression |
| Q40038133 | Epidermal growth factor receptor-targeted therapy. |
| Q37628728 | Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors |
| Q35558949 | Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation |
| Q37230970 | Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review |
| Q34863536 | Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate |
| Q34721752 | MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals |
| Q33562476 | Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK |
| Q35722192 | MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma |
| Q36457506 | Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines |
| Q38869420 | Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology |
| Q37861191 | NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia |
| Q37676970 | Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function |
| Q39670051 | Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654 |
| Q42324659 | Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signaling |
| Q38238609 | PI3K/Akt-mediated regulation of p53 in cancer |
| Q28240702 | PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR |
| Q34042708 | Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity |
| Q33831934 | Proteomic analysis of effects by x-rays and heavy ion in HeLa cells |
| Q36955707 | Proteomic analysis of energy metabolism and signal transduction in irradiated melanoma cells |
| Q37912205 | Proteomics revisits the cancer metabolome |
| Q47768906 | RUBCN/rubicon and EGFR regulate lysosomal degradative processes in the retinal pigment epithelium (RPE) of the eye. |
| Q37024025 | Radiation-induced EGFR-signaling and control of DNA-damage repair |
| Q39940485 | Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. |
| Q38244964 | Radiation-induced signaling pathways that promote cancer cell survival (review). |
| Q38710560 | Radioprotective Agents: Strategies and Translational Advances. |
| Q38226307 | Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications |
| Q50436009 | Somatic PI3K activity regulates transition to the spermatocyte stages in Drosophila testis. |
| Q35665493 | TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway. |
| Q61805942 | Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response |
| Q38819242 | Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers |
| Q93021945 | The Role of Fgf Signaling on Epithelial Cell Differentiation in Mouse Vagina |
| Q34039540 | The effects of amphiregulin induced MMP-13 production in human osteoarthritis synovial fibroblast |
| Q39644498 | The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells |
| Q39490125 | Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status |
| Q54489564 | [Molecular signaling pathways. Mechanisms and clinical use]. |
Search more.